RT Journal Article
SR Electronic
T1 469 Combining a safe PI3Kd inhibitor with chemotherapy and anti-PD1 in immunotherapy-refractory NSCLC: a proof-of-concept study to allow clinical trial design
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A527
OP A527
DO 10.1136/jitc-2023-SITC2023.0469
VO 11
IS Suppl 1
A1 Riganti, Chiara
A1 Scagliotti, Giorgio
A1 Novello, Silvia
A1 Tabbo, Fabrizio
A1 Righi, Luisella
A1 Neff, Laurence
A1 Lahn, Michael
A1 Veen, Lars Van der
A1 Conza, Giusy Di
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A527.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.